Manav Sohal1, Anoop Shetty2, Steven Niederer2, Angela Lee2, Zhong Chen2, Tom Jackson2, Jonathan M Behar2, Simon Claridge2, Julian Bostock3, Eoin Hyde2, Reza Razavi2, Frits Prinzen4, C Aldo Rinaldi5. 1. Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; Cardiovascular Department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom,. Electronic address: manav.sohal@gstt.nhs.uk. 2. Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom. 3. Cardiovascular Department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. 4. Maastricht University Medical Center, Cardiovascular Research Institute (CARIM), Maastricht, The Netherlands. 5. Division of Imaging Sciences and Biomedical Engineering, King's College London, London, United Kingdom; Cardiovascular Department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Abstract
BACKGROUND: Multisite pacing (MSP) of the left ventricle is proposed as an alternative to conventional single-site LV pacing in cardiac resynchronization therapy (CRT). Reports on the benefits of MSP have been conflicting. A paradigm whereby not all patients derive benefit from MSP is emerging. OBJECTIVE: We sought to compare the hemodynamic and electrical effects of MSP with the aim of identifying a subgroup of patients more likely to derive benefit from MSP. METHODS: Sixteen patients with implanted CRT systems incorporating a quadripolar LV pacing lead were studied. Invasive hemodynamic and electroanatomic assessment was performed during the following rhythms: baseline (non-CRT); biventricular (BIV) pacing delivered via the implanted CRT system (BIV(implanted)); BIV pacing delivered via an alternative temporary LV lead (BIV(alternative)); dual-vein MSP delivered via 2 LV leads; MultiPoint Pacing delivered via 2 vectors of the quadripolar LV lead. RESULTS: Seven patients had an acute hemodynamic response (AHR) of <10% over baseline rhythm with BIV(implanted) and were deemed nonresponders. AHR in responders vs nonresponders was 21.4% ± 10.4% vs 2.0% ± 5.2% (P < .001). In responders, neither form of MSP provided incremental hemodynamic benefit over BIV(implanted). Dual-vein MSP (8.8% ± 5.7%; P = .036 vs BIV(implanted)) and MultiPoint Pacing (10.0% ± 12.2%; P = .064 vs BIV(implanted)) both improved AHR in nonresponders. Seven of 9 responders to BIV(implanted) had LV endocardial activation characterized by a functional line of block during intrinsic rhythm that was abolished with BIV pacing. All these patients met strict criteria for left bundle branch block (LBBB). No nonresponders exhibited this line of block or met strict criteria for LBBB. CONCLUSION: Patients not meeting strict criteria for LBBB appear most likely to derive benefit from MSP.
BACKGROUND: Multisite pacing (MSP) of the left ventricle is proposed as an alternative to conventional single-site LV pacing in cardiac resynchronization therapy (CRT). Reports on the benefits of MSP have been conflicting. A paradigm whereby not all patients derive benefit from MSP is emerging. OBJECTIVE: We sought to compare the hemodynamic and electrical effects of MSP with the aim of identifying a subgroup of patients more likely to derive benefit from MSP. METHODS: Sixteen patients with implanted CRT systems incorporating a quadripolar LV pacing lead were studied. Invasive hemodynamic and electroanatomic assessment was performed during the following rhythms: baseline (non-CRT); biventricular (BIV) pacing delivered via the implanted CRT system (BIV(implanted)); BIV pacing delivered via an alternative temporary LV lead (BIV(alternative)); dual-vein MSP delivered via 2 LV leads; MultiPoint Pacing delivered via 2 vectors of the quadripolar LV lead. RESULTS: Seven patients had an acute hemodynamic response (AHR) of <10% over baseline rhythm with BIV(implanted) and were deemed nonresponders. AHR in responders vs nonresponders was 21.4% ± 10.4% vs 2.0% ± 5.2% (P < .001). In responders, neither form of MSP provided incremental hemodynamic benefit over BIV(implanted). Dual-vein MSP (8.8% ± 5.7%; P = .036 vs BIV(implanted)) and MultiPoint Pacing (10.0% ± 12.2%; P = .064 vs BIV(implanted)) both improved AHR in nonresponders. Seven of 9 responders to BIV(implanted) had LV endocardial activation characterized by a functional line of block during intrinsic rhythm that was abolished with BIV pacing. All these patients met strict criteria for left bundle branch block (LBBB). No nonresponders exhibited this line of block or met strict criteria for LBBB. CONCLUSION: Patients not meeting strict criteria for LBBB appear most likely to derive benefit from MSP.
Authors: Antonios P Antoniadis; Ben Sieniewicz; Justin Gould; Bradley Porter; Jessica Webb; Simon Claridge; Jonathan M Behar; Christopher Aldo Rinaldi Journal: Curr Heart Fail Rep Date: 2017-10
Authors: Antonios P Antoniadis; Jonathan M Behar; Simon Claridge; Tom Jackson; Manav Sohal; Christopher Aldo Rinaldi Journal: Curr Cardiol Rep Date: 2016-07 Impact factor: 2.931
Authors: Mark K Elliott; Vishal Mehta; Nadeev Wijesuriya; Baldeep S Sidhu; Justin Gould; Steven Niederer; Christopher A Rinaldi Journal: Eur Heart J Open Date: 2022-02-26
Authors: Luuk I B Heckman; Marion Kuiper; Frederic Anselme; Filippo Ziglio; Nicolas Shan; Markus Jung; Stef Zeemering; Kevin Vernooy; Frits W Prinzen Journal: Heart Rhythm O2 Date: 2020-06-15
Authors: Maciej Sterliński; Adam Sokal; Radosław Lenarczyk; Frederic Van Heuverswyn; C Aldo Rinaldi; Marc Vanderheyden; Vladimir Khalameizer; Darrel Francis; Joeri Heynens; Berthold Stegemann; Richard Cornelussen Journal: PLoS One Date: 2016-04-28 Impact factor: 3.240